Cargando…
COVID-19: is the rush to boost backed by science?
Autor principal: | The Lancet Rheumatology |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550896/ https://www.ncbi.nlm.nih.gov/pubmed/34725648 http://dx.doi.org/10.1016/S2665-9913(21)00330-1 |
Ejemplares similares
-
High-stakes heterogeneity in COVID-19
por: The Lancet Rheumatology
Publicado: (2020) -
COVID-19: a time to reflect
por: The Lancet Rheumatology
Publicado: (2020) -
COVID-19 vaccine data provide reassurance
por: The Lancet Rheumatology
Publicado: (2021) -
Going viral: misinformation in the time of COVID-19
por: The Lancet Rheumatology
Publicado: (2021) -
Novel COVID-19 therapies: the road ahead for rheumatology
por: The Lancet Rheumatology
Publicado: (2022)